The Week in Review: Tigermed, a Hangzhou CRO, Plans IPO
22:33 EDT 4 Aug 2012 | ChinaBio Today
Tigermed Consulting, the clinical-stage CRO headquartered in Hangzhou, will stage an IPO on the ChiNext exchange, with pricing expected August 6; Covidien officially opened its China medical device R&D facility in Shanghai’s Caohejing Hi..
Original Article: The Week in Review: Tigermed, a Hangzhou CRO, Plans IPO
More From BioPortfolio on "The Week in Review: Tigermed, a Hangzhou CRO, Plans IPO"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
